HIV topic update: protease inhibitor therapy and oral health care.
Protease inhibitors have been a major advance in the management of HIV disease and have reduced the frequency and severity of many complications, including some oral lesions. They may also be of value in the management of occupational exposures to the virus. However, they may produce adverse effects including oral symptoms such as paraesthesia, taste disturbances and xerostomia, and may interact with a number of drugs used in oral health care. This article summarises the current situation.
|Title:||HIV topic update: protease inhibitor therapy and oral health care.|
|Keywords:||Administration, Oral, Dental Care for Chronically Ill, Drug Interactions, HIV Infections, HIV Protease Inhibitors, Humans, Mouth Diseases, Occupational Exposure|
|UCL classification:||UCL > School of Life and Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Eastman Dental Institute
Archive Staff Only